Nanoparticle-based drug delivery: Case studies for cancer and cardiovascular applications

Cellular and Molecular Life Sciences

Volumn 69, Issue 3, 2012, Pages 389-404

  Galvin, Paul ^a   Thompson, Damien ^a   Ryan, Katie B ^b   McCarthy, Anna ^b   Moore, Anne C ^b   Burke, Conor S ^c   Dyson, Maya ^c   MacCraith, Brian D ^c   Gun'Ko, Yurii K ^d   Byrne, Michelle T ^d   Volkov, Yuri ^d   Keely, Chris ^d   Keehan, Enda ^e   Howe, Michael ^e   Duffy, Conor ^f   MacLoughlin, Ronan ^f  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e Creganna Tactx Medical   (Ireland)

^f Aerogen Ltd   (Ireland)

Author keywords

Cancer; Cardiovascular; Controlled drug release; Drug delivery; Nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; AURANOFIN; AUROTHIOMALATE; CAPLOSTATIN; CHITOSAN; CISPLATIN; CYCLODEXTRIN; CYT 21001; CYT 6091; DENDRIMER; DIDODECYLDIMETHYLAMMONIUM BROMIDE; DOXORUBICIN; ETHER LIPID; FUMAGILLOL CHLOROACETYLCARBAMATE; GOLD NANOPARTICLE; INSULIN; MACROGOL; NANOMATERIAL; NANOPARTICLE; PACLITAXEL; POLY(METHYL METHACRYLATE); POLYACRYLAMIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIDE; POLYMER; POLYVINYL ALCOHOL; QUANTUM DOT; SOLID LIPID NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOAVAILABILITY; BIOCOMPATIBILITY; BIODEGRADABILITY; CARDIOVASCULAR DISEASE; CONTROLLED RELEASE FORMULATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; HUMAN; HYDROLYSIS; HYDROPHILICITY; LIPID OXIDATION; MOLECULAR DYNAMICS; NANOENGINEERING; NANOTECHNOLOGY; NEOPLASM; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PULMONARY HYPERTENSION; PYROLYSIS; RETICULOENDOTHELIAL SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATOID ARTHRITIS; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DRUG CARRIERS; DRUG-ELUTING STENTS; HUMANS; NANOPARTICLES; NEOPLASMS; POLYMERS;

EID: 84856179625     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0856-6     Document Type: Review

References (171)

1. J Panyam V Labbhasetwar 2003 Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv Drug Deliv Rev 55 329 347 12628320 1:CAS:528:DC%2BD3sXhs1Cgurw%3D 10.1016/S0169-409X(02)00228-4 (Pubitemid 36297053)
2. AH Faraji P Wipf 2009 Nanoparticles in cellular drug delivery Bioorg Med Chem 17 2950 2962 19299149 1:CAS:528:DC%2BD1MXksVWlur0%3D 10.1016/j.bmc.2009.02. 043
3. K Loomis K McNeeley RV Bellamkonda 2011 Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications Soft Matter 7 3 839 856 1:CAS:528:DC%2BC3MXhtVWitrk%3D 10.1039/c0sm00534g
4. X Su X Zhan F Tang JY Yao J Wu 2011 Magnetic nanoparticles in brain disease diagnosis and targeting drug delivery Curr Nanosci 7 1 37 46 1:CAS:528:DC%2BC3MXlslekurs%3D 10.2174/157341311794480363
5. N Khlebtsov L Dykman 2011 Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies Chem Soc Rev 40 3 1647 1671 21082078 1:CAS:528:DC%2BC3MXit1KisLk%3D 10.1039/c0cs00018c
6. KT Fitzgerald CA Holladay C McCarthy KA Power A Pandit WM Gallagher 2011 Standardization of models and methods used to assess nanoparticles in cardiovascular applications SMALL 7 6 705 717 21319299 1:CAS:528: DC%2BC3MXjsFyrtb4%3D 10.1002/smll.201001347
7. KC Petkar SS Chavhan S Agatonovik-Kustrin KK Sawant 2011 Nanostructured materials in drug and gene delivery: a review of the state of the art Cri Rev Ther Drug Carr Sys 28 2 101 164 1:CAS:528:DC%2BC3MXlvVWmt7o%3D
8. S Das A Chaudhury 2011 Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery AAPS Pharmscitech 12 1 62 76 21174180 1:CAS:528:DC%2BC3MXjvFKmt7o%3D 10.1208/s12249-010-9563-0
9. YY Cheng LB Zhao YW Li TW Xu 2011 Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives Chem Soc Rev 40 5 2673 2703 21286593 1:CAS:528:DC%2BC3MXkvVWjtb0%3D 10.1039/c0cs00097c
10. A Schroeder CG Levins C Cortez R Langer DG Anderson 2010 Lipid-based nanotherapeutics for siRNA delivery J Intern Med 267 1 9 21 20059641 1:CAS:528:DC%2BC3cXhtFOmtro%3D 10.1111/j.1365-2796.2009.02189.x
11. T Kaasgaard TL Andresen 2010 Liposomal cancer therapy: exploiting tumor characteristics Expert Opin Drug Deliv 7 2 225 243 20095944 1:CAS:528: DC%2BC3cXht1Sms7g%3D 10.1517/17425240903427940
12. M Slevin L Badimon M Grau-Olivares M Ramis J Sendra M Morrison J Krupinski 2010 Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis Mol Biosys 6 3 444 450 1:CAS:528:DC%2BC3cXit1Sntro%3D 10.1039/b916175a
13. P Ruenraroengsak JM Cook AT Florence 2010 Nanosystem drug targeting: facing up to complex realities J Control Release 141 3 265 276 19895862 1:CAS:528:DC%2BC3cXht1Kls74%3D 10.1016/j.jconrel.2009.10.032
14. RA Petros JM DeSimone 2010 Strategies in the design of nanoparticles for therapeutic applications Nat Rev Drug Discov 9 8 615 627 20616808 1:CAS:528:DC%2BC3cXosFeltbk%3D 10.1038/nrd2591
15. N Duceppe M Tabrizian 2010 Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery Expert Opin Drug Deliv 7 10 1191 1207 20836623 1:CAS:528:DC%2BC3cXhtFyltLnJ 10.1517/17425247.2010.514604
16. DJ Bharali SA Mousa 2010 Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise Pharmacol Ther 128 2 324 335 20705093 1:CAS:528:DC%2BC3cXht1Wjtb3O 10.1016/j.pharmthera.2010.07.007
17. N Tran TJ Webster 2010 Magnetic nanoparticles: biomedical applications and challenges J Mater Chem 20 40 8760 8767 1:CAS:528:DC%2BC3cXht1Clsb%2FO 10.1039/c0jm00994f
18. P Zrazhevskiy M Sena XH Gao 2010 Designing multifunctional quantum dots for bioimaging, detection, and drug delivery Chem Soc Rev 39 11 4326 4354 20697629 1:CAS:528:DC%2BC3cXhtlShtbzM 10.1039/b915139g
19. Y Malam M Loizidou AM Seifalian 2009 Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol Sci 30 11 592 599 19837467 1:CAS:528:DC%2BD1MXhtlCku7zI 10.1016/j.tips.2009.08.004
20. A Puri K Loomis B Smith JH Lee A Yavlovich E Heldman R Blumenthal 2009 Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit Rev Ther Drug Carr Sys 26 6 523 580 1:CAS:528:DC%2BC3cXntVaks7Y%3D
21. H Devalapally A Chakilam M Amiji 2007 Role of nanotechnology in pharmaceutical product development J Pharm Sci 96 2547 2565 17688284 1:CAS:528:DC%2BD2sXhtFKrtLnK 10.1002/jps.20875 (Pubitemid 47603100)
22. Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S (2009) Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 30:6065-6075
23. O Choi ZQ Hu 2008 Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria Environ Sci Technol 42 4583 4588 18605590 1:CAS:528:DC%2BD1cXlslOjsLk%3D 10.1021/es703238h (Pubitemid 351842410)
24. O Bar-Ilan RM Albrecht VE Fako, et al. 2009 Toxicity assessments of multisized gold and silver nanoparticles in Zebrafish embryos SMALL 5 1897 1910 19437466 1:CAS:528:DC%2BD1MXps1ykurg%3D 10.1002/smll.200801716
25. M Tarantola A Pietuch D Schneider, et al. 2011 Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells Nanotoxicology 5 2 254 268 1:CAS:528:DC%2BC3MXhtFCqurrP
26. H Jin DA Heller R Sharma, et al. 2009 Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles ACS NANO 3 1 149 158 19206261 1:CAS:528:DC%2BD1MXhslOntw%3D%3D 10.1021/nn800532m
27. SR Chae AR Badireddy JF Budarz, et al. 2010 Heterogeneities in fullerene nanoparticle aggregates affecting reactivity, bioactivity, and transport ACS NANO 4 9 5011 5018 20707347 1:CAS:528:DC%2BC3cXhtVWqt7jM 10.1021/nn100620d
28. ER Gillies JMJ Frechet 2005 pH-responsive copolymer assemblies for controlled release of doxorubicin Bioconj Chem 16 361 368 1:CAS:528: DC%2BD2MXhtF2jsL8%3D 10.1021/bc049851c (Pubitemid 40388212)
29. Xie Y AillonKL N El-Gendy Laird BerklandCJ M Forrest 2009 Effects of nanomaterial physicochemical properties on in vivo toxicity Adv Drug Deliv Rev 61 457 466 10.1016/j.addr.2009.03.010 1:CAS:528:DC%2BD1MXmsF2js7o%3D
30. AP Alivisatos KP Johnsson X Peng, et al. 1996 Organization of 'nanocrystal molecules' using DNA Nature 382 609 611 8757130 1:CAS:528:DyaK28XltVWqsrY%3D 10.1038/382609a0 (Pubitemid 26268950)
31. R Chhabra J Sharma Y Liu, et al. 2010 DNA self-assembly for nanomedicine Adv Drug Deliv Rev 62 6 617 625 20230866 1:CAS:528:DC%2BC3cXntVelt7o%3D 10.1016/j.addr.2010.03.005
32. RH Muller K Mader ÈS Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur J Pharma Biopharma 50 161 177 1:CAS:528:DC%2BD3cXjslyisrg%3D 10.1016/S0939-6411(00)00087- 4 (Pubitemid 30326695)
33. MM van Schooneveld E Vucic R Koole, et al. 2008 Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation Nanoletters 8 8 2517 2525 10.1021/nl801596a 1:CAS:528:DC%2BD1cXosVejt7Y%3D
34. Stevens PJ, Sekido M, Lee RJ (2004) A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res 21(12):2153-2157 (Pubitemid 40568428)
35. W Liu Z He J Liang Y Zhu H Xu X Yang 2008 Preparation and characterization of novel fluorescent nanocomposite particles: CdSe/ZnS core-shell quantum dots loaded solid lipid nanoparticles J Biomed Mater Res Part A 84A 1018 1:CAS:528:DC%2BD1cXisVarsLk%3D 10.1002/jbm.a.31205 (Pubitemid 351295012)
36. DP Cormode R Chandrasekar A Delshad, et al. 2009 Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis Bioconj Chem 20 5 937 943 1:CAS:528:DC%2BD1MXkslamt70%3D 10.1021/bc800520d
37. S Franzen 2011 A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle Expert Opin Drug Deliv 8 3 281 298 21306284 1:CAS:528:DC%2BC3MXit1Wlsrg%3D 10.1517/17425247.2011.554816
38. B Chen W Wu X Wang 2011 Magnetic iron oxide nanoparticles for tumor-targeted therapy Curr Cancer Drug Targets 11 2 184 189 21158723 1:CAS:528:DC%2BC3MXhsVels7g%3D 10.2174/156800911794328475
39. ML Tan PFM Choong CR Dass 2010 Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery Peptides 31 1 184 193 19819278 1:CAS:528:DC%2BC3cXpt1en 10.1016/j.peptides.2009.10.002
40. O Veiseh JW Gunn MQ Zhang 2010 Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging Adv Drug Deliv Rev 62 3 284 304 19909778 1:CAS:528:DC%2BC3cXit1Ont7s%3D 10.1016/j.addr.2009.11.002
41. Sundar S, Kundu J, Kundu SC (2010) Biopolymeric nanoparticles. Sci Technol Adv Mater 11(1): Art No. 014104 2010
42. W Schartl 2010 Current directions in core-shell nanoparticle design Nanoscale 2 6 829 843 20644772 1:CAS:528:DC%2BC3cXhtlKru7jK 10.1039/c0nr00028k
43. K Nagpal SK Singh DN Mishra 2010 Chitosan nanoparticles: a promising system in novel drug delivery Chem Pharm Bull 58 11 1423 1430 21048331 1:CAS:528:DC%2BC3cXhs1artrvN 10.1248/cpb.58.1423
44. S Laurent D Forge M Port A Roch C Robic LV Elst RN Muller 2008 Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem Rev 108 6 2064 2110 18543879 1:CAS:528:DC%2BD1cXmvFCjtb0%3D 10.1021/cr068445e
45. AK Gupta M Gupta 2005 Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26 18 3995 4021 15626447 1:CAS:528:DC%2BD2MXisFWr 10.1016/j.biomaterials.2004.10.012 (Pubitemid 40044762)
46. AH Lu EL Salabas F Schuth 2007 Magnetic nanoparticles: synthesis, protection, functionalisation, and application Angewandte Chemie-Int Ed 46 8 1222 1244 1:CAS:528:DC%2BD2sXitF2lurs%3D 10.1002/anie.200602866 (Pubitemid 46981367)
47. L Shen PE Laibinis TA Hatton 1999 Bilayer surfactant stabilized magnetic fluids: synthesis and interactions at interfaces Langmuir 15 447 453 1:CAS:528:DyaK1cXotFaiurg%3D 10.1021/la9807661
48. L Shen A Stachowiak SEK Fateen PE Laibinis TA Hatton 2001 Structure of alkanoic acid stabilized magnetic fluids. A small-angle neutron and light scattering analysis Langmuir 17 2 288 299 1:CAS:528:DC%2BD3cXoslKjsbk%3D 10.1021/la9916732 (Pubitemid 32159111)
49. M Racuciu DE Creanga G Calugaru 2005 Synthesis and rheological properties of an aqueous ferrofluid J Optoelectron Adv Mater 7 6 2859 2864 1:CAS:528:DC%2BD28Xnt1KhtA%3D%3D (Pubitemid 43004054)
50. M Racuciu DE Creanga A Airinei 2006 Citric-acid-coated magnetite nanoparticles for biological applications Eur Phy J E 21 2 117 121 1:CAS:528:DC%2BD2sXhs1yit70%3D 10.1140/epje/i2006-10051-y (Pubitemid 44970437)
51. MAJ Hodenius T Niendorf GA Krombach W Richtering T Eckert H Lueken M Speldrich RW Gunther M Baumann SJH Soenen M De Cuyper T Schmitz-Rode 2008 Synthesis, physicochemical characterization and MR relaxometry of aqueous ferrofluids J Nanosci Nanotechnol 8 5 2399 2409 18572655 1:CAS:528: DC%2BD1cXmslWqs7c%3D 10.1166/jnn.2008.312 (Pubitemid 351570299)
52. TW Prow WA Rose N Wang LM Reece Y Lvov JF Leary 2005 Biosensor-controlled gene therapy/drug delivery with nanoparticles for nanomedicine Proc SPIE 5692 199 208 1:CAS:528:DC%2BD2MXktlKntbk%3D 10.1117/12.589422 (Pubitemid 40954230)
53. JB Smitham R Evans DH Napper 1975 Analytical theories of steric stabilization of colloidal dispersions J Chem Soc-Faraday Transac I 71 2 285 297 1:CAS:528:DyaE2MXht12lu7s%3D 10.1039/f19757100285
54. R Evans DH Napper 1977 Perturbation method for incorporating concentration-dependence of Flory-Huggins parameter in the theory of steric stabilization J Chem Soc-Faraday Transac I 73 1377 1385 1:CAS:528:DyaE1cXnsFal 10.1039/f19777301377
55. AS Barnard 2010 Modelling of nanoparticles: approaches to morphology and evolution Rep Prog Phys 73 086502 10.1088/0034-4885/73/8/086502 1:CAS:528:DC%2BC3cXhtFahsbjP
56. J Lin H Zhang Z Chen Y Zheng 2010 Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship ACS Nano 284 9 5421 5429 10.1021/nn1010792 1:CAS:528: DC%2BC3cXhtVOmtrjM
57. AS Arbab LB Wilson P Ashari EK Jordan BK Lewis JA Frank 2005 A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging NMR Biomed 18 6 383 389 16013087 1:CAS:528:DC%2BD2MXhtF2nsbbO 10.1002/nbm.970 (Pubitemid 41410358)
58. HS Lee EH Kim HP Shao BK Kwak 2005 Synthesis of SPIO-chitosan microspheres for MRI-detectable embolotherapy J Magn Magn Mater 293 1 102 105 1:CAS:528:DC%2BD2MXktVahtb8%3D 10.1016/j.jmmm.2005.01.049 (Pubitemid 40608916)
59. HS Lee HP Shao YQ Huang BK Kwak 2005 Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan IEEE Transac Magn 41 10 4102 4104 1:CAS:528:DC%2BD2MXht1aqsr%2FN 10.1109/TMAG.2005.855338 (Pubitemid 41584669)
60. SJ Lee JR Jeong SC Shin JC Kim YH Chang YM Chang JD Kim 2004 Nanoparticles of magnetic ferric oxides encapsulated with poly(d, l latide-co-glycolide) and their applications to magnetic resonance imaging contrast agent J Magn Magn Mater 272 76 2432 2433 10.1016/j.jmmm.2003.12.416 1:CAS:528:DC%2BD2cXksFOnsbc%3D (Pubitemid 41066984)
61. FX Hu KG Neoh ET Kang 2006 Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles Biomaterials 27 33 5725 5733 16890989 1:CAS:528:DC%2BD28Xos12qtbo%3D 10.1016/j.biomaterials.2006. 07.014 (Pubitemid 44294822)
62. JWM Bulte M de Cuyper D Despres JA Frank 1999 Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent J Magn Magn Mater 194 204 209 1:CAS:528:DyaK1MXitVKltrY%3D 10.1016/S0304-8853(98)00556-3
63. MD Shultz S Calvin PP Fatouros SA Morrison EE Carpenter 2007 Enhanced ferrite nanoparticles as MRI contrast agents J Magn Magn Mater 311 1 464 468 1:CAS:528:DC%2BD2sXjtVeiu7k%3D 10.1016/j.jmmm.2006.10.1188 (Pubitemid 46401047)
64. M-S Martina J-P Fortin C Ménager O Clément G Barratt C Grabielle-Madelmont F Gazeau V Cabuil S Lesieur 2005 Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging J Am Chem Soc 127 10676 10685 16045355 1:CAS:528: DC%2BD2MXlvVKhtLw%3D 10.1021/ja0516460 (Pubitemid 41061441)
65. N Nitin LEW LaConte O Zurkiya X Hu G Bao 2004 Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent J Biol Inorg Chem 9 6 706 712 15232722 1:CAS:528: DC%2BD2cXnt1Grt7s%3D 10.1007/s00775-004-0560-1 (Pubitemid 39279249)
66. N Kohler GE Fryxell MQ Zhang 2004 A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents J Am Chem Soc 126 23 7206 7211 15186157 1:CAS:528:DC%2BD2cXktFCqtLg%3D 10.1021/ja049195r (Pubitemid 38747770)
67. H Ai C Flask B Weinberg X Shuai MD Pagel D Farrell J Duerk JM Gao 2005 Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes Adv Mater 17 16 1949 1:CAS:528:DC%2BD2MXpsFGis70%3D 10.1002/adma.200401904 (Pubitemid 41206143)
68. Z Li L Wei MY Gao H Lei 2005 One-pot reaction to synthesize biocompatible magnetite nanoparticles Adv Mater 17 8 1001 10.1002/adma.200401545 1:CAS:528:DC%2BD2MXjslagurw%3D (Pubitemid 40584337)
69. C Sun R Sze MQ Zhang 2006 Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI J Biomed Mater Res Part A 78A 3 550 557 1:CAS:528:DC%2BD28XosVeltrs%3D 10.1002/jbm.a.30781 (Pubitemid 44253539)
70. 4 nanoparticles for reduced non-specific uptake by macrophage cells Adv Mater 19 20 3163 1:CAS:528:DC%2BD2sXht12jt7rI 10.1002/adma.200701975 (Pubitemid 350044454)
71. 4 nanoparticles: synthesis, characterization and cellular uptake Biomaterials 28 36 5426 5436 17892896 1:CAS:528:DC%2BD2sXht1WqtbnE 10.1016/j.biomaterials.2007.08.039 (Pubitemid 47610690)
72. Y Wang YW Ng Y Chen B Shuter J Yi J Ding SC Wang SS Feng 2008 Formulation of superparamagnetic iron oxides by nanoparticles of biodegradable polymers for magnetic resonance imaging Adv Func Mater 18 2 308 318 1:CAS:528: DC%2BD1cXhvVOmtrc%3D 10.1002/adfm.200700456 (Pubitemid 351212312)
73. FQ Hu L Wei Z Zhou YL Ran Z Li MY Gao 2006 Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer Adv Mater 18 19 2553 1:CAS:528:DC%2BD28XhtFWqtLrO 10.1002/adma.200600385 (Pubitemid 44563472)
74. C Sun O Veiseh J Gunn C Fang S Hansen D Lee R Sze RG Ellenbogen J Olson M Zhang 2008 In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes Small 4 3 372 379 18232053 1:CAS:528: DC%2BD1cXjvFertb4%3D 10.1002/smll.200700784 (Pubitemid 351421268)
75. CH Dodd HC Hsu WJ Chu PG Yang HG Zhang JD Mountz K Zinn J Forder L Josephson R Weissleder JM Mountz JD Mountz 2001 Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator- peptide-derived superparamagnetic nanoparticles J Immunol Methods 256 1-2 89 105 11516758 1:CAS:528:DC%2BD3MXmtFSqsbc%3D 10.1016/S0022-1759(01)00433-1 (Pubitemid 32769920)
76. C Dodd J Mountz WJ Chu L Josephson HG Zhang R Weissleder JM Mountz K Zinn JD Mountz HC Hsu 2001 In vivo magnetic resonance imaging (MRI) of T cells loaded with HIV transactivator (tat) peptide-derived super-paramagnetic nanoparticles Faseb J 15 5 A744 A744
77. HC Hsu C Dodd WJ Chu PA Yang L Josephson SH Sun HG Zhang R Weissleder JD Mountz 2001 Normal response of T cells loaded with HIV transactivator (tat) peptide-derived super-paramagnetic nanoparticles for magnetic resonance imaging (MRI) Faseb J 15 4 A330 A330
78. N Asongkla E Bey JM Ren H Ai C Khemtong JS Guthi SF Chin AD Sherry DA Boothman JM Gao 2006 Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems Nano Lett 6 11 2427 2430 10.1021/nl061412u 1:CAS:528:DC%2BD28XhtFSls7%2FK (Pubitemid 46076928)
79. C von zur Muhlen D von Elverfeldt N Bassler I Neudorfer B Steitz A Petri-Fink H Hofmann CPK Bode 2007 Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques Atherosclerosis 193 1 102 111 10.1016/j.atherosclerosis.2006.08.048 1:CAS:528:DC%2BD2sXlvFamtrg%3D (Pubitemid 46776715)
80. MS Martina Menager C FortinJP O Clement G Barratt C Grabielle-Madelmont F Gazeau V Cabuil S Lesieur 2005 Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging J Am Chem Soc 127 30 10676 10685 16045355 1:CAS:528:DC%2BD2MXlvVKhtLw%3D 10.1021/ja0516460 (Pubitemid 41061441)
81. Larsen BA, Haag MA, Serkova NJ, Shroyer KR, Stoldt CR (2008) Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes. Nanotechnology 19(26): 265102. doi: 10.1088/0957-4484/19/26/265102 (Pubitemid 351813720)
82. M Meincke T Schlorf E Kossel O Jansen CC Glueer R Mentlein 2008 Iron oxide-loaded liposomes for MR imaging Frontiers Biosci 13 4002 4008 1:CAS:528:DC%2BD1cXnsVKqurk%3D 10.2741/2987 (Pubitemid 351599672)
83. KL Hultman AJ Raffo AL Grzenda PE Harris TR Brown S O'Brien 2008 Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles Acs Nano 2 3 477 484 19206573 1:CAS:528:DC%2BD1cXislKqt7Y%3D 10.1021/nn700400h
84. SJ Byrne SA Corr YK Gun'ko JM Kelly DF Brougham S Ghosh 2004 Magnetic nanoparticle assemblies on denatured DNA show unusual magnetic relaxivity and potential applications for MRI Chem Commun 22 2560 2561 10.1039/b409603g 1:CAS:528:DC%2BD2cXps1Glsb8%3D (Pubitemid 39593320)
85. AP Philipse MPB Vanbruggen C Pathmamanoharan 1994 Magnetic silica dispersions-preparation and stability of surface-modified silica particles with a magnetic core Langmuir 10 1 92 99 1:CAS:528:DyaK2cXmtlaqtw%3D%3D 10.1021/la00013a014
86. F Yan H Xu J Anker R Kopelman B Ross A Rehemtulla R Reddy 2004 Synthesis and characterization of silica-embedded iron oxide nanoparticles for magnetic resonance imaging J Nanosci Nanotechnol 4 1-2 72 76 15112544 1:CAS:528:DC%2BD2cXivVyntr4%3D 10.1166/jnn.2004.074 (Pubitemid 38594978)
87. S Liang YX Wang CF Zhang XQ Liu ZF Liu RH Xu DZ Yin 2006 Synthesis of amino-modified magnetite nanoparticles coated with Hepama-1 and radiolabeled with Re-188 for bio-magnetically targeted radiotherapy J Radioanal Nucl Chem 269 1 3 7 1:CAS:528:DC%2BD28Xnt1Kmsrc%3D 10.1007/s10967-006-0223-5 (Pubitemid 44127107)
88. S Santra R Tapec N Theodoropoulou J Dobson A Hebard WH Tan 2001 Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of non-ionic surfactants Langmuir 17 10 2900 2906 1:CAS:528:DC%2BD3MXislKhtr4%3D 10.1021/la0008636 (Pubitemid 35330470)
89. P Tartaj CJ Serna 2002 Microemulsion-assisted synthesis of tuneable superparamagnetic composites Chem Mater 14 10 4396 4402 1:CAS:528: DC%2BD38XntV2ku7w%3D 10.1021/cm021214d
90. P Tartaj CJ Serna 2003 Synthesis of monodisperse superparamagnetic Fe/silica nanospherical composites J Am Chem Soc 125 51 15754 15755 14677960 1:CAS:528:DC%2BD3sXptlGqur0%3D 10.1021/ja0380594 (Pubitemid 37553687)
91. HH Yang SQ Zhang XL Chen ZX Zhuang JG Xu XR Wang 2004 Magnetite-containing spherical silica nanoparticles for biocatalysis and bioseparations Anal Chem 76 5 1316 1321 14987087 1:CAS:528: DC%2BD2cXmtFamtg%3D%3D 10.1021/ac034920m (Pubitemid 38280478)
92. EE Carpenter C Sangregorio CJ O'Connor 1999 Effects of shell thickness on blocking temperature of nanocomposites of metal particles with gold shells IEEE Transac Magn 35 5 3496 3498 1:CAS:528:DyaK1MXnt1Srsb0%3D 10.1109/20.800568 (Pubitemid 32261367)
93. SJ Cho JC Idrobo J Olamit K Liu ND Browning SM Kauzlarich 2005 Growth mechanisms and oxidation resistance of gold-coated iron nanoparticles Chem Mater 17 12 3181 3186 1:CAS:528:DC%2BD2MXjvFyktL0%3D 10.1021/cm0500713 (Pubitemid 40850391)
94. JI Park J Cheon 2001 Synthesis of "solid solution" and "core-shell" type cobalt-platinum magnetic nanoparticles via transmetalation reactions J Am Chem Soc 123 24 5743 5746 11403607 1:CAS:528:DC%2BD3MXjslGksbw%3D 10.1021/ja0156340 (Pubitemid 32904708)
95. ZH Ban YA Barnakov VO Golub CJ O'Connor 2005 The synthesis of core-shell iron@gold nanoparticles and their characterization J Mater Chem 15 43 4660 4662 1:CAS:528:DC%2BD2MXhtFKqtrbE 10.1039/b504304b (Pubitemid 41677553)
96. JL Lyon DA Fleming MB Stone P Schiffer ME Williams 2004 Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding Nano Lett 4 4 719 723 1:CAS:528:DC%2BD2cXit1SqtLo%3D 10.1021/nl035253f (Pubitemid 38586640)
97. J Kim S Park JE Lee SM Jin JH Lee IS Lee I Yang JS Kim SK Kim MH Cho T Hyeon 2006 Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy Angewandte Chemie-Int Ed 45 46 7754 7758 1:CAS:528:DC%2BD28Xht12rs7zF 10.1002/anie.200602471 (Pubitemid 44871335)
98. T Hayashi S Hirono M Tomita S Umemura 1996 Magnetic thin films of cobalt nanocrystals encapsulated in graphite-like carbon Nature 381 6585 772 774 10.1038/381772a0 (Pubitemid 26243113)
99. SI Nikitenko Y Koltypin Felner I PalchikO XN Xu A Gedanken 2001 Synthesis of highly magnetic, air-stable iron iron carbide nanocrystalline particles by using power ultrasound Angewandte Chemie-Int Ed 40 23 4447 1:CAS:528: DC%2BD3MXptlWhtLs%3D 10.1002/1521-3773(20011203)40:23<4447::AID- ANIE4447>3.0.CO;2-J (Pubitemid 34000401)
100. SS Davis 2004 Coming of age of lipid-based drug delivery systems Adv Drug Deliv Rev 56 1241 1242 15109766 1:CAS:528:DC%2BD2cXjtl2ktro%3D 10.1016/j.addr.2004.02.001 (Pubitemid 38510471)
101. AS UlrichAS 2002 Biophysical aspects of using liposomes as delivery vehicles Biosci Rep 22 2 129 150 10.1023/A:1020178304031 (Pubitemid 35222729)
102. HL Wong R Bendayan AM Rauth XY Wu 2004 Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers J Pharma Sci 93 8 1993 1:CAS:528:DC%2BD2cXmvVKktL8%3D 10.1002/jps.20100 (Pubitemid 39045481)
103. A Brioschi GP Zara S Calderoni MR Gasco A Mauro 2008 Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug Molecules 13 230 254 18305415 1:CAS:528:DC%2BD1cXhvFCnurs%3D 10.3390/molecules13020230
104. AJ Almeida E Souto 2007 Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv Drug Deliv Rev 59 478 490 17543416 1:CAS:528:DC%2BD2sXpt1Cqtrk%3D 10.1016/j.addr.2007.04.007 (Pubitemid 47260710)
105. A del Pozo-Rodríguez S Pujals D Delgado MA Solinís AR Gascón E Giralt JL Pedraz 2009 A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors J Control Release 133 52 59 18854203 10.1016/j.jconrel.2008.09.004 1:CAS:528: DC%2BD1cXhsVKnur3E
106. KC Partlow GM Lanza SA Wickline 2008 Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery Biomaterials 29 3367 3375 18485474 1:CAS:528:DC%2BD1cXmsFahsLw%3D 10.1016/j.biomaterials.2008.04.030
107. SK Huang E Mayhew S Gilani D Lasic FJ Martin D Papahadjopoulos 1992 Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma Cancer Res 52 6774 6781 1458465 1:CAS:528:DyaK3sXltF2quw%3D%3D (Pubitemid 23006277)
108. X Wu Y Deng G Wang K Tao 2007 Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells J Surg Res 138 1 56 63 17169374 1:CAS:528:DC%2BD2sXhvVyqsrY%3D 10.1016/j.jss.2006.06.027 (Pubitemid 46227454)
109. M Schmitt-Sody S Strieth S Krasnici B Sauer B Schulze M Teifel 2003 Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy Clin Cancer Res 9 2335 2341 12796403 1:CAS:528:DC%2BD3sXksVajs70%3D (Pubitemid 36687660)
110. S Sebastian EE Martin S Birgitta S Brita T Michael M Uwe D Marc 2004 Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature Int J Cancer 110 117 124 10.1002/ijc.20083 1:CAS:528:DC%2BD2cXjtlKqsbk%3D (Pubitemid 38507211)
111. K Furumoto J-I Yokoe K-I Ogawara S Amano M Takaguchi K Higaki T Kai T Kimura 2007 Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition Int J Pharma 329 110 116 1:CAS:528:DC%2BD28XhtlCmtLvN 10.1016/j.ijpharm.2006.08.026 (Pubitemid 44937532)
112. J-I Yokoe S Sakuragi K Yamatoto T Teragaki K-I Ogowara K Higaki N Katayama T Kai M Sato T Kimura 2008 Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats Int J Pharma 353 28 34 1:CAS:528:DC%2BD1cXivFKisLY%3D 10.1016/j.ijpharm.2007.11.008
113. C Fonseca JN Moreira CJ Ciudad MC Pedroso de Lima S Simoes 2005 Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells Eur J Pharma Biopharma 59 359 366 1:CAS:528:DC%2BD2MXmtlGhtw%3D%3D 10.1016/j.ejpb.2004.08.012 (Pubitemid 40127593)
114. S Anabousi U Bakowski M Schneider H Huwer C-M Lehr C Ehrhardt 2006 In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer Eur J Pharma Sci 29 367 374 1:CAS:528:DC%2BD28XhtF2qurzP 10.1016/j.ejps.2006.07.004 (Pubitemid 44709858)
115. S Anabousi E Kleeman U Bakowski T Kissel T Schneider T Gessler W Seeger C-M Lehr C Ehrhardt 2006 Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant J Nanosci Nanotechnol 6 3010 3016 17048512 1:CAS:528:DC%2BD28XhtVKnsr%2FP 10.1166/jnn.2006.461 (Pubitemid 44579976)
116. DC Drummond CO Noble ME Hayes JW Park DB Kirpotin 2008 Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development J Pharm Sci 97 11 4696 4740 18351638 1:CAS:528:DC%2BD1cXhtlCgsLbN 10.1002/jps.21358
117. Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD (2011) Secretory phospholipase A2 responsive liposomes. J Pharm Sci. Article first published online: 31 MAR 2011
118. TL Andresen SS Jensen K Jørgensen 2005 Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog Lipid Res 44 1 68 97 15748655 1:CAS:528:DC%2BD2MXhvVCjtb8%3D 10.1016/j.plipres.2004.12.001 (Pubitemid 40313220)
119. SS Jensen TL Andresen J Davidsen P Høyrup SD Shnyder MC Bibby JH Gill K Jørgensen 2004 Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids Mol Cancer Ther 3 11 1451 1458 15542784 1:CAS:528: DC%2BD2cXpslCktLs%3D (Pubitemid 39562590)
120. Huang L LiS-D 2006 Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells Mol Pharm 3 579 588 10.1021/mp060039w 1:CAS:528:DC%2BD28XmslWgs7o%3D (Pubitemid 44639135)
121. JD Byrne T Betancourt L Brannon-Peppas 2008 Active targeting schemes for nanoparticle systems in cancer therapeutics Adv Drug Deliv Rev 60 1615 1626 18840489 1:CAS:528:DC%2BD1cXhsVSjsL%2FP 10.1016/j.addr.2008.08.005
122. RK Visaria RJ Griffin BW Williams ES Ebbini GF Paciotti CW Song JC Bischo 2006 Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-A delivery Mol Cancer Ther 5 4 1014 1020 16648573 1:CAS:528:DC%2BD28XjvFCksLw%3D 10.1158/1535-7163.MCT-05-0381 (Pubitemid 43724602)
123. JM Farma M Puhlmann PA Soriano D Cox GF Paciotti L Tamarkin HR Alexander 2007 Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor Int J Cancer 120 2474 2480 1:CAS:528: DC%2BD2sXksFSkurY%3D (Pubitemid 46642137)
124. Bahtia NS et al. (2009) US Patent Application 2009/0093551
125. J Klostergaard J Bankson E Auzenne D Gibson W Yuill CE Seeney 2007 Magnetic vectoring of magnetically responsive nanoparticles within the murine peritoneum J Magn Magn Mater 311 1 330 335 1:CAS:528:DC%2BD2sXjtVeitLY%3D 10.1016/j.jmmm.2006.10.1163 (Pubitemid 46401016)
126. J Kim JE Lee SH Lee JH Yu JH Lee TG Park T Hyeon 2008 Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery Adv Mater 20 3 478 1:CAS:528:DC%2BD1cXlt1Wnt7c%3D 10.1002/adma.200701726
127. R Jurgons C Seliger A Hilpert L Trahms S Odenbach C Alexiou 2006 Drug loaded magnetic nanoparticles for cancer therapy J Phys Condens Matter 18 38 S2893 S2902 1:CAS:528:DC%2BD28XhtFelsr%2FK 10.1088/0953-8984/18/38/S24 (Pubitemid 44523008)
128. S Hanessian JA Grzyb F Cengelli L Juillerat-Jeanneret 2008 Synthesis of chemically functionalized superparamagnetic nanoparticles as delivery vectors for chemotherapeutic drugs Bioorg Med Chem 16 6 2921 2931 18226908 1:CAS:528:DC%2BD1cXktFersbg%3D 10.1016/j.bmc.2007.12.051 (Pubitemid 351418211)
129. E Segal R Satchi-Fainaro 2009 Design and development of polymer conjugates as anti-angiogenic agents Adv Drug Deliv Rev 61 1159 1176 19699248 1:CAS:528:DC%2BD1MXhtlWhtL7O 10.1016/j.addr.2009.06.005
130. K Miller R Erez E Segal D Shabat R Satchi-Fainaro 2009 Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate- taxane conjugate Angew Chem Int Ed Engl 48 2949 2954 19294707 1:CAS:528:DC%2BD1MXkvVemsLg%3D 10.1002/anie.200805133
131. H Dai X Jiang GC Tan Y Chen M Torbenson KW Leong HQ Mao 2006 Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery Int J Nanomed 1 4 507 522 1:CAS:528:DC%2BD2sXjs1Wiur0%3D 10.2147/nano.2006.1.4.507
132. P Pradhana 2010 Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J Control Release 142 1 108 121 10.1016/j.jconrel.2009.10. 002 1:CAS:528:DC%2BC3cXhs1SgsLc%3D
133. SG Spiro GA Silvestri 2005 One hundred years of lung cancer Am J Respir Crit Care Med 172 5 523 529 15961694 10.1164/rccm.200504-531OE (Pubitemid 41232963)
134. F Celikoglu SI Celikoglu EP Goldberg 2008 Techniques for intratumoral chemotherapy of lung cancer by bronchoscopic drug delivery Cancer Ther 6 545 552 1:CAS:528:DC%2BD1MXmsFSms78%3D
135. F Celikoglu SI Celikoglu EP Goldberg 2010 Intratumoural chemotherapy of lung cancer for diagnosis and treatment of draining lymph node metastasis J Pharm Pharmacol 62 3 287 295 20487210 1:CAS:528:DC%2BC3cXkt1entbc%3D 10.1211/jpp.62.03.0001
136. TL Andresen SS Jensen K Jørgensen 2005 Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog Lipid Res 44 68 97 15748655 1:CAS:528:DC%2BD2MXhvVCjtb8%3D 10.1016/j.plipres.2004.12.001 (Pubitemid 40313220)
137. K Taylor JM Newton 1992 Liposomes for controlled delivery of drugs to the lung Thorax 47 257 259 1585287 1:STN:280:DyaK383mtlanug%3D%3D 10.1136/thx.47.4.257
138. SJ Farr IW Kellaway DR Parry-Jones SG Woolfrey 1985 99 m-Technetium as a marker of liposomal deposition and clearance in the human lung Int J Pharma 26 303 316 1:CAS:528:DyaL2MXmtV2qsLw%3D 10.1016/0378-5173(85)90239-X (Pubitemid 16228628)
139. J Liu, et al. 2008 Solid lipid nanoparticles for pulmonary delivery of insulin Int J Pharma 356 333 344 1:CAS:528:DC%2BD1cXlsFCks7g%3D 10.1016/j.ijpharm.2008.01.008
140. T Ku, et al. 2008 Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential J Nanosci Nanotechnol 8 2971 2978 18681033 1:CAS:528:DC%2BD1cXotlKku7o%3D 10.1166/jnn.2008.171
141. CA Kavanagh YA Rochev WM Gallagher KA Dawson AK Keenan 2004 Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems Pharmacol Ther 102 1 15 15056495 1:CAS:528:DC%2BD2cXisl2kt7c%3D 10.1016/j.pharmthera.2003.01.001 (Pubitemid 38429982)
142. MJ Bennett M O'Sullivan 2001 Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy Pharmacol Ther 91 149 166 11728607 1:CAS:528:DC%2BD3MXos1Cms7o%3D 10.1016/S0163-7258(01)00153-X (Pubitemid 33139799)
143. HM Burta WL Hunter 2006 Drug-eluting stents: a multidisciplinary success story Adv Drug Deliv Rev 58 3 350 357 10.1016/j.addr.2006.01.014 1:CAS:528:DC%2BD28Xltl2jsro%3D (Pubitemid 43816738)
144. BL van der Hoeven NM Pires HM Warda PV Oemrawsingh BJ van Vlijmen PH Quax MJ Schalij EE van der Wall JW Jukema 2005 Drug-eluting stents: results, promises and problems Int J Cardiol 99 1 9 17 15721493 10.1016/j.ijcard.2004.01. 021 (Pubitemid 40261018)
145. G Acharyab K Park 2006 Mechanisms of controlled drug release from drug-eluting stents Adv Drug Deliv Rev 58 3 387 401 10.1016/j.addr.2006.01.016 1:CAS:528:DC%2BD28Xltl2jsrk%3D (Pubitemid 43816741)
146. ™ drug-eluting stent: a new paradigm in controlled drug delivery Adv Drug Deliv Rev 58 3 412 436 16647782 1:CAS:528:DC%2BD28Xltl2jsrc%3D 10.1016/j.addr.2006.01. 023 (Pubitemid 43949060)
147. PK Kuchulakanti WW Chu R Torguson P Ohlmann SW Rha LC Clavijo, et al. 2006 Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents Circulation 113 1108 1113 16490815 1:CAS:528:DC%2BD28Xhs1Gru7Y%3D 10.1161/CIRCULATIONAHA.105.600155
148. I Sheiban G Villata M Bollati D Sillano M Lotrionte G Biondi-Zoccai 2008 Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V) Vasc Health Risk Manag 4 1 31 38 18629361 1:CAS:528:DC%2BD1cXkslKqu7o%3D 10.2147/vhrm.2008.04.01.31 (Pubitemid 351467378)
149. I Iakovou T Schmidt E Bonizzoni L Ge GM Sangiorgi G Stankovic, et al. 2005 Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA-J Am Med Assoc 293 2126 2130 1:CAS:528:DC%2BD2MXjvFKiu7w%3D 10.1001/jama.293.17.2126 (Pubitemid 40617065)
150. SH Lee I Szinai K Carpenter R Katsarava G Jokhadze CC Chu, et al. 2002 In vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer Coron Artery Dis 13 237 241 12193851 1:CAS:528:DC%2BD38XltVWqu74%3D 10.1097/00019501-200206000-00006
151. Wickline SA, Neubauer AM, Winter PM, Caruthers SD, Lanza GM (2007) Molecular imaging and therapy of Atherosclerosis with targeted nanoparticles. J Magn Reson Imaging 25:667-680 (Pubitemid 46516717)
152. K Park H-Y Hong HJ Moon B-H Lee I-S Kim IC Kwon K Rhee 2008 A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides J Control Release 128 217 223 18457896 1:CAS:528:DC%2BD1cXmvVCrs78%3D 10.1016/j.jconrel.2008.03.019
153. WJM Mulder GJ Strijkers KC Briley-Saboe, et al. 2007 Molecular imaging of macrophages in antherosclerotic plaques using bimodal PEG-micelles Magn Reson Med 58 6 1164 1170 18046703 10.1002/mrm.21315 (Pubitemid 350234203)
154. P Broz S Marsch P Hunzikel 2007 Targeting of vulnerable plaque macrophages with polymer-based nanostructures Trends in Cardiovasc Medic 17 6 190 1:CAS:528:DC%2BD2sXot1ymsr4%3D 10.1016/j.tcm.2007.05.002 (Pubitemid 47089008)
155. Peters D et al. (2009) Targeting atherosclerosis by using modular, multifunctional micelles. PNAS 106(24): 9815-9819
156. PP Karmali, et al. 2008 Targeting of albumin-embedded paclitaxel nanoparticles to tumors Nanomedicine 5 73 82 18829396
157. MLT Zweers GHM Engbers DW Grijpma J Feijen 2006 Release of anti-restenosis drugs from poly(ethylene oxide)-poly(dl-lactic-co-glycolic acid) nanoparticles J Control Release 114 317 324 16884807 1:CAS:528: DC%2BD28Xpt1Omtbo%3D 10.1016/j.jconrel.2006.05.021 (Pubitemid 44310811)
158. R Tong J Cheng 2008 Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles Angew Chem 47 4830 4834 1:CAS:528:DC%2BD1cXnvF2nsLs%3D 10.1002/anie.200800491
159. UB-TL Westedt AK Schaper 2002 Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy AAPS PharmSci 44 1 6
160. U Westedt M Kalinowski M Wittmar T Merdan F Unger J Fuchs S Schaller U Bakowsky T Kissel 2007 Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment J Control Release 119 41 51 17346845 1:CAS:528:DC%2BD2sXksVejtLo%3D 10.1016/j.jconrel.2007.01.009 (Pubitemid 46561540)
161. LA Orloff AJ Domb D Teomim I Fishbein G Golomb 1997 Biodegradable implant strategies for inhibition of restenosis Adv Drug Deliv Rev 24 3 9 1:CAS:528:DyaK2sXmsVSlsg%3D%3D 10.1016/S0169-409X(96)00478-4 (Pubitemid 27062757)
162. E Cohen-Sela O Rosenweig J Gao H Epstein I Gati R Reich HD Dananberg G Golomb 2006 Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis J Control Release 113 23 30 16697068 1:CAS:528:DC%2BD28Xlt12rt7Y%3D 10.1016/j.jconrel.2006.03.010 (Pubitemid 43818160)
163. L Brito M Amiji 2007 Nanoparticulate carriers for the treatment of coronary restenosis Int J Nanomed 2 143 161 1:CAS:528:DC%2BD2sXpsFGkurs%3D 10.2217/17435889.2.2.143 (Pubitemid 46845764)
164. XIY Zou WCG N Zhang 2009 New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles Drug Deliv 16 15 23 10.1080/ 10717540802481307 1:CAS:528:DC%2BD1MXktVWrtbw%3D
165. LA Orloff MG Glenn AJ Domb RA Esclamado 1995 Prevention of venous thrombosis in microvascular surgery by transmural release of heparin from a polyanhydride polymer Surgery 117 554 559 7740427 1:STN:280:DyaK2M3lvV2gtg%3D%3D 10.1016/S0039-6060(05)80255-7
166. U Westedt Schaper AK Barbu-TudoranL M Kalinowski H Alfke T Kissel 2004 Effects of different application parameters on penetration characteristics and arterial vessel wall integrity after local nanoparticle delivery using a porous balloon catheter Eur J Pharma Biopharma 58 161 168 1:CAS:528: DC%2BD2cXltVGhu7c%3D 10.1016/j.ejpb.2004.03.009 (Pubitemid 38781017)
167. JR McCarthy JM Perez C Bruckner R Weissleder 2005 Polymeric nanoparticle preparation that eradicate tumors Nano Lett 5 2552 2556 16351214 1:CAS:528:DC%2BD2MXht1Smt77J 10.1021/nl0519229 (Pubitemid 43088911)
168. L-M Lacroix D Ho S Sun 2010 Magnetic nanoparticles as both imaging probes and therapeutic agents Curr Top Med Chem 10 1184 1197 20388109 1:CAS:528:DC%2BC3cXpslSlsr0%3D 10.2174/156802610791384207
169. MaierSA MaherRC LF Cohen L Koh A Laromaine JAG Dick MM Stevens 2010 Exploiting SERS hot spots for disease-specific enzyme detection J Phys Chem C114 16 7231 7235
170. D Khang J Carpenter YW Chun R Pareta TJ Webster 2010 Nanotechnology for regenerative medicine Biomed Microdevices 12 4 575 587 19096767 1:CAS:528:DC%2BC3cXotlyhs7o%3D 10.1007/s10544-008-9264-6
171. AJ Salgado JM Oliveira RP Pirraco VH Pereira JS Fraga AP Marques NM Neves JF Mano RL Reis N Sousa 2010 Carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles in central nervous systems-regenerative medicine: effects on neuron/glial cell viability and internalization efficiency Macromol Biosci 10 10 1130 1140 20602413 1:CAS:528:DC%2BC3cXhsVSqsLjO 10.1002/mabi.201000005